Mustang Bio
Price & Volume
Stats
See moreOpen | $1.02 |
Previous Close | $1.03 |
Day Range | $1.01-$1.02 |
52W Range | $0.53-$3.68 |
Market Cap | $7.5M |
Shares Short | 43,589 |
Financials
See moreRevenue (12 Mos) | -$50,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$6.71 |
News
See moreYahoo Finance • 5 months ago
7 Biotech Stocks Trading At 52-Week Highs - Can The Rally Continue?
Yahoo Finance • 8 months ago
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
Yahoo Finance • 8 months ago
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
Yahoo Finance • 12 months ago
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
About
CEO | Dr. Manuel Litchman M.D. |
CFO | Dr. Manuel Litchman M.D. |
Address | 95 Sawyer Road, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |
